Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Clinical Trial
NCT03931785Last updated: 12/4/2025
IRWD
IRONWOOD PHARMACEUTICALS INC